Makers Laboratories
146.05
-2.65(-1.78%)
Market Cap₹86.14 Cr
PE Ratio14.91
IndustryHealthcare
Company Performance:
1D-1.78%
1M-6.35%
6M+6.26%
1Y-3.50%
5Y-41.85%
View Company Insightsright
More news about Makers Laboratories
08Aug 25
Makers Laboratories Reports Mixed Q1 Results: Standalone Loss, Consolidated Profit
Makers Laboratories Ltd reported mixed Q1 financial results. Standalone operations showed a net loss of Rs 121.89 crore and 21% lower revenue at Rs 970.07 crore. However, consolidated results improved with a net profit of Rs 43.67 crore, despite a 15.5% decrease in revenue to Rs 2,959.17 crore. The Chemical Manufacturing segment outperformed the Pharmaceutical segment, contributing significantly to the consolidated profit. CEO Samhita Parikh emphasized the company's commitment to improving operational efficiency and capitalizing on growth opportunities.
 no imag found
Makers Laboratories
146.05
-2.65
(-1.78%)
1 Year Returns:-3.50%
Industry Peers
Sun Pharmaceutical
1,680.10
(+0.62%)
Divis Laboratories
6,378.50
(+1.48%)
Torrent Pharmaceuticals
4,147.20
(+1.53%)
Dr Reddys Laboratories
1,331.00
(+9.37%)
Lupin
2,341.40
(+1.45%)
Cipla
1,305.90
(+5.63%)
Zydus Life Science
946.35
(+1.77%)
Mankind Pharma
2,292.90
(+2.59%)
Aurobindo Pharma
1,435.40
(+1.00%)
Alkem Laboratories
5,520.50
(-1.89%)